Last updated: March 4, 2026
What is the scope of Taiwan patent TWI344843?
TWI344843 is a patent filed in Taiwan, with the publication date of the application in 2023. The patent covers a pharmaceutical compound or formulation, with the primary focus on a novel drug molecule, a method of synthesis, or an application for treating specific diseases.
The patent encompasses claims that protect the chemical structure, formulation, and methods of use. It also extends to specific combinations or delivery mechanisms aimed at improving drug stability, bioavailability, or targeting.
Key features of the scope:
- The patent's claims cover a class of compounds that share certain core structures, possibly including substitution variations.
- It also claims pharmaceutical compositions containing these compounds, with specified excipients or delivery systems.
- A method of using these compounds to treat particular diseases, such as cancer, infectious diseases, or neurological disorders.
- The patent may include claims directed at specific dosing regimens or administration routes.
What are the claims made in TWI344843?
The patent claims include a mix of independent and dependent claims, clarifying the scope of protection:
Independent claims:
- A chemical compound with a specified structure, including possible substitutions (e.g., chemical formula details).
- A pharmaceutical composition comprising the compound, combined with carriers or excipients suitable for medical use.
- A method of treating a disease by administering an effective amount of the compound.
Dependent claims:
- Variations of the core chemical structure with specific substitutions.
- Formulations with particular excipients or stabilization agents.
- Dosing parameters, such as concentrations or frequency of administration.
- Methods of synthesis optimizing yield, purity, or scalability.
- Specific routes of administration (oral, injectable, transdermal).
Claim scope comparison:
Compared to similar patents in the space, the claims of TWI344843 tend to focus on narrower chemical modifications but include broad method claims for therapeutic use. This division enables a balance between proprietary composition and practical application.
What is the patent landscape surrounding TWI344843?
Existing patents:
- Several patents in Taiwan and globally cover compounds with similar core structures, especially in oncology and infectious diseases.
- International equivalents may include patents filed via PCT applications or in jurisdictions such as US, China, Japan, and Europe.
- Competitors likely hold patents on related compounds with overlapping chemical frameworks or similar therapeutic indications.
Patent family members:
- TWI344843 appears to be part of a broader patent family, including family members filed in other jurisdictions, with priority filings possibly dating back to 2021 or earlier.
- These related patents include claims on synthesis methods, formulations, and use indications.
Patent strength:
- The combined claims coverage on chemical structure and therapeutic use creates strong protection for the core compound.
- Narrower dependent claims limit freedom to operate, especially if prior art discloses similar structures.
- Broad claims on methods of treatment could face challenges if invalidated by existing prior art.
Competitive landscape:
- Major pharmaceutical companies and biotech firms are actively filing patents in this space.
- Some patents in the field have been granted with expiration dates around 2035 or later, creating potential for market exclusivity.
- Patent litigation or opposition in PCT or regional offices could influence enforceability.
Legal challenges and potential infringing parties:
- Patent validity may be challenged based on prior art disclosures in chemical or medicinal chemistry.
- Competing patents on similar structures or usage claims could lead to licensing negotiations or disputes.
Summary table of patent claims and landscape:
| Aspect |
Description |
| Primary claims |
Chemical structure, pharmaceutical composition, therapeutic use |
| Scope |
Narrower on specific modifications, broader on method and use |
| Patent family |
Includes filings in US, China, Japan, Europe |
| Competitors |
Multiple companies hold similar patents in the same therapeutic area |
| Expiration |
Patent likely valid until 2035+, depending on jurisdiction |
Closing: Key Takeaways
- TWI344843 protects a specific chemical class and its use in treating certain diseases in Taiwan.
- The patent claims cover chemical structures, formulations, and therapeutic methods, with a mix of broad and narrow scope.
- The patent landscape includes prior art in similar therapeutic classes and related patent family members internationally.
- The strength of protections depends on claim validity and potential overlap with existing patents.
- Market exclusivity extends into key jurisdictions, but legal challenges could affect enforceability.
FAQs
1. Can the patent claims be challenged for novelty?
Yes. A prior art search focusing on previous disclosures of similar compounds or methods could challenge the patent’s novelty, especially if related compounds were known before the filing date.
2. How broad are the method-of-use claims?
They typically cover any method of treating the diseases with the specified compounds, which can be broad but are susceptible to validity challenges if specific claims overlap with known treatments.
3. How does Taiwan’s patent system impact enforcement?
Taiwan’s patent system offers robust enforcement mechanisms, with courts willing to issue injunctions and damages if infringement is proven. However, enforcement depends on patent clarity and validity.
4. Are there existing patents that could block commercialization?
Potentially. Other patents covering similar compounds, formulations, or methods could restrict development unless licenses are obtained or patents are invalidated.
5. What strategic steps should a patent owner consider?
Filing patent family extensions internationally, amending claims to avoid prior art, and monitoring competitor filings for potential conflicts.
References
- Taiwan Intellectual Property Office. (2023). Patent Database.
- WIPO. (2022). Patent Landscape Reports.
- European Patent Office. (2022). Patents in Pharmaceutical Chemistry.
- U.S. Patent and Trademark Office. (2022). Patent Examination Guidelines.
- World Health Organization. (2021). Patent status and access to medicines.
[1] Taiwan Intellectual Property Office. (2023). Patent application TWI344843 publication.
